Friday, 9 Dec 2022

Medications

Journalists Discuss Medicaid Rules, Opioid Settlement Funds, and the Public Health Workforce

KHN correspondent Sam Whitehead discussed Georgia’s push for Medicaid work requirements on WABE’s “All Things Considered” on Nov. 28. Click here to hear Whitehead on “All Things Considered” Read Whitehead’s “Path Cleared for Georgia to Launch Work Requirements for Medicaid” KHN correspondent Aneri Pattani discussed how states are distributing opioid settlement funds on NPR’s “All […]

After Congress Fails to Add Dental Coverage, Medicare Weighs Limited Benefit Expansion

Proposed changes in Medicare rules could soon pave the way for a significant expansion in Medicare-covered dental services, while falling short of the comprehensive benefits that many Democratic lawmakers have advocated. That’s because, under current law, Medicare can pay for limited dental care only if it is medically necessary to safely treat another covered medical […]

Los hospitales derivan pacientes de atención primaria a centros de salud “semejantes” para mejorar las finanzas

Cada vez más hospitales subcontrantan servicios ambulatorios, a menudo poco rentables, para los pacientes más pobres, mediante la creación de organizaciones independientes, sin fines de lucro, que proporcionan atención primaria. Medicare y Medicaid pagan a estas clínicas, conocidas como centros de salud semejantes con certificación federal, mucho más de lo que pagarían si fueran propiedad […]

At a Tennessee Crossroads, Two Pharmacies, a Monkey, and Millions of Pills

CELINA, Tenn. — It was about 1 a.m. on April 19, 2016, when a burglary alarm sounded at Dale Hollow Pharmacy in Celina, a tiny town in the rolling, wooded hills near the Kentucky border. Two cops responded. As their flashlights bobbed in the darkness, shining through the pharmacy windows, they spotted a sign of […]

FDA Approves Welireg

FDA Approves Welireg (belzutifan) for the Treatment of Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors KENILWORTH, N.J.–(BUSINESS WIRE) August 13, 2021 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Welireg, an oral hypoxia-inducible factor-2 alpha […]

FDA Approves Saphnelo

FDA Approves Saphnelo (anifrolumab) for Moderate to Severe Systemic Lupus Erythematosus 2 August 2021 — AstraZeneca’s Saphnelo (anifrolumab-fnia) has been approved in the US for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy.1 The approval by the Food and Drug Administration (FDA) was based on […]

Recent Posts